Atopic Dermatitis
📧 Sign up to get email alerts when something new happens for Atopic Dermatitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: A Study to Assess the Effects of Nemolizumab on Cytochrome P450 Substrates in Participants With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 trial evaluated whether nemolizumab affects cytochrome P450–mediated drug metabolism in adults with moderate-to-severe atopic derm…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AK120 in Subjects With Moderate to Severe Atopic Dermatitis [Phase 2]
Phase 2 clinical trial evaluating the safety and efficacy of AK120 in adults with moderate to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-12Clinical Trial Update: Targeted Investigation of Microbiome Elimination [Phase 1]
Phase 1 trial investigating targeted microbiome elimination for atopic dermatitis was terminated. Results were posted on 2024-11-12.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of CM310 in Children Patients With Moderate-to-severe Atopic Dermatis [Phase 2]
Phase 2 clinical trial of CM310 in pediatric patients with moderate-to-severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: The Study of CM310 in Patients With Atopic Dermatitis [Phase 2]
This document announces the completion of a Phase 2 clinical trial evaluating CM310 in adults with moderate-to-severe atopic dermatitis.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: A Study of CM310 in Patients With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial CM310 in moderate-to-severe Atopic Dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-11-08Clinical Trial Update: Determine the Dose-dependent Efficacy and Safety of EC-18 in Patients With Moderate to Severe Atopic Dermatitis [Phase 2]
A Phase 2 clinical trial update evaluating the dose-dependent efficacy and safety of EC-18 in adults with moderate to severe Atopic Dermatit…
-
CLINICAL_TRIALS trial_result · 2024-11-06Clinical Trial Update: A Study of Lebrikizumab in Combination With Topical Corticosteroids in Patients With Atopic Dermatitis (AD) That Are Not Adequately Controlled With or Are Non-eligible for Cyclosporine [Phase 3]
A Phase 3 study evaluating Lebrikizumab in combination with topical corticosteroids for atopic dermatitis not adequately controlled with cyc…
-
CLINICAL_TRIALS trial_result · 2024-11-05Clinical Trial Update: A Study, Comparing Ruxolitinib Topical Cream 1.5% (Taro Pharmaceuticals U.S.A, Inc.) to OPZELURA (Ruxolitinib) Cream for the Treatment of Mild-to-Moderate Atopic Dermatitis. [Phase 1]
A Phase 1 study comparing Ruxolitinib topical cream 1.5% (Taro Pharmaceuticals) with OPZELURA (Ruxolitinib) Cream for mild-to-moderate atopi…
-
CLINICAL_TRIALS trial_result · 2024-11-04Clinical Trial Update: A Clinical Trial in Subjects With Atopic Dermatitis (Part 1) [Phase 2]
Phase 2 clinical trial in atopic dermatitis completed; this update provides status for Part 1 of the study.
-
CLINICAL_TRIALS trial_result · 2024-10-30Clinical Trial Update: Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis [Phase 3]
Phase 3 trial update reporting long-term safety and efficacy of nemolizumab in adults with moderate-to-severe atopic dermatitis; status indi…
-
CLINICAL_TRIALS trial_result · 2024-10-26Clinical Trial Update: Study of ATI-1777 in Patients 12 to 65 Years Old With Mild to Severe Atopic Dermatitis [Phase 2]
Phase 2 study ATI-1777 in patients aged 12-65 with mild to severe atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of CM310 Injection in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 2]
A Phase 2 trial of CM310 injection for moderate-to-severe atopic dermatitis has completed; the update summarizes the study status and outcom…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Skin Responses and T Cell Immunology After House Dust Mite Exposure in Sensitized Atopic Dermatitis Patients [NA]
This clinical trial update reports skin responses and T cell immunology following house dust mite exposure in individuals with sensitized at…
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis [Phase 1, Phase 2]
Phase 1/2 trial CM310 in pediatric patients with moderate-to-severe atopic dermatitis has completed; the study was conducted by Keymed Biosc…
-
CLINICAL_TRIALS trial_result · 2024-10-09Clinical Trial Update: Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis [Phase 3]
A Phase 3 trial evaluated roflumilast, a PDE4 inhibitor, for the management of atopic dermatitis; the study has completed and results were p…
-
CLINICAL_TRIALS trial_result · 2024-10-04Clinical Trial Update: Trial of PDE4 Inhibition With Roflumilast for the Management of Atopic Dermatitis (INTEGUMENT-II) [Phase 3]
Phase 3 INTEGUMENT-II trial evaluating roflumilast, a PDE4 inhibitor, for the management of atopic dermatitis has completed and results have…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: A Study to Learn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis. [Phase 2]
Phase 2 trial PF-07038124 in patients with Atopic dermatitis and Plaque psoriasis has completed, with results posted on 2024-10-02.
-
CLINICAL_TRIALS trial_result · 2024-09-24Clinical Trial Update: A Study to Assess Subcutaneous Lirentelimab (AK002) in Atopic Dermatitis [Phase 2]
Phase 2 trial evaluating subcutaneous lirentelimab (AK002) for atopic dermatitis was terminated, and results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: A Study to Learn About Abrocitinib Tablets in People With Atopic Dermatitis in India [Phase 3]
A Phase 3 study evaluating abrocitinib tablets for atopic dermatitis in India has completed, and the trial results have been posted.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Efficacy of Marine By-product Hydrolysate on the Reduction of Atopic Dermatitis Symptoms [NA]
Completed clinical trial evaluating the efficacy of marine by-product hydrolysate in reducing Atopic Dermatitis symptoms.
-
CLINICAL_TRIALS trial_result · 2024-08-21Clinical Trial Update: Efficacy of Dipotassium Glycyrrhizinate Emollients in the Maintenance Treatment of Adult Atopic Dermatitis [NA]
Clinical trial update on the maintenance use of dipotassium glycyrrhizinate emollients for adults with atopic dermatitis; study status is co…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: Ruxolitinib Cream in Participants With Facial and/or Neck Atopic Dermatitis Involvement [Phase 2]
Phase 2 study evaluating ruxolitinib cream for facial/neck involvement in atopic dermatitis; the trial has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2024-08-15Clinical Trial Update: This Study is to Assess the Efficacy of Difamilast Ointment in Mild to Moderate Atopic Dermatitis(AD) [Phase 3]
A Phase 3 study evaluating the efficacy of difamilast ointment in patients with mild to moderate atopic dermatitis has completed.
-
CLINICAL_TRIALS trial_result · 2024-08-14Clinical Trial Update: Efficacy and Safety of Nemolizumab in Subjects With Moderate-to-Severe Atopic Dermatitis [Phase 3]
Phase 3 trial results evaluating the efficacy and safety of nemolizumab in adults with moderate-to-severe atopic dermatitis have been posted…